13G/A filed by Decheng Capital Global Life Sciences Fund IV, L.P.
Decheng Capital Global Life Sciences Fund IV, L.P. and 2 other reporting persons reported 2,724,868 UPB shares, 4.9% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-10-29 20:13:09 UTC.
- Accession
- 0001834150-26-000006
- Filer
- CIK 1834150
- Filed
- 2026-10-29
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- UPB · Upstream Bio, Inc.
- Shares
- 2,724,868
- Percent of class
- 4.9%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: every reporting person reports the same shares (a chain of control). The page shows the largest row.
Read for the filer group Decheng Capital Global Life Sciences Fund IV, L.P..
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P. | PN | 0 | 2,724,868 | 0 | 2,724,868 | 2,724,868 | 4.9% |
| Decheng Capital Management IV (Cayman), LLC | OO | 0 | 2,724,868 | 0 | 2,724,868 | 2,724,868 | 4.9% |
| Xiangmin Cui | IN | 0 | 2,724,868 | 0 | 2,724,868 | 2,724,868 | 4.9% |